| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 88.90▼ | 89.15▼ | 88.74▲ | 87.66▲ | 84.99▲ |
| MA10 | 89.06▼ | 88.67▲ | 88.19▲ | 85.83▲ | 86.99▲ |
| MA20 | 89.19▼ | 88.15▲ | 87.93▲ | 84.78▲ | 86.48▲ |
| MA50 | 88.63▲ | 87.51▲ | 86.42▲ | 87.34▲ | 85.27▲ |
| MA100 | 88.15▲ | 86.14▲ | 84.78▲ | 86.73▲ | 86.82▲ |
| MA200 | 87.95▲ | 84.60▲ | 86.48▲ | 86.63▲ | 85.13▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.088▼ | 0.070▲ | 0.047▲ | 0.711▲ | -0.130▼ |
| RSI | 46.407▼ | 60.996▲ | 63.265▲ | 59.103▲ | 54.461▲ |
| STOCH | 11.644▼ | 87.708▲ | 80.239▲ | 89.063▲ | 46.214 |
| WILL %R | -87.879▼ | -30.688 | -21.682▲ | -6.792▲ | -25.118 |
| CCI | -96.712 | 56.843 | 120.211▲ | 143.410▲ | 36.698 |
|
Thursday, May 01, 2025 06:23 AM
Doximity thrives on user growth and pharma marketing momentum, but its stock may be overvalued. Read why DOCS stock is a Hold.
|
|
Tuesday, April 29, 2025 03:04 AM
Key Insights Amdocs' estimated fair value is US$148 based on 2 Stage Free Cash Flow to Equity Amdocs' US$86.78 ...
|
|
Monday, April 28, 2025 11:27 PM
2-Year U.S. Treasury Note Continuous Contract $103.918-0.043-0.04% 5-Year U.S. Treasury Note Continuous Contract $108.820-0.109-0.10% 10-Year U.S. Treasury Note Continuous Contract $111.766-0.141 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 88.90 | 89.46 | 88.38 | 88.88 | 123,587 |
| 30/04/25 | 87.61 | 88.72 | 86.60 | 88.58 | 691,295 |
| 29/04/25 | 87.20 | 88.57 | 86.94 | 88.07 | 411,112 |
| 28/04/25 | 86.43 | 87.49 | 86.07 | 86.78 | 658,217 |
| 25/04/25 | 85.90 | 86.43 | 85.525 | 86.01 | 478,566 |
| 24/04/25 | 85.10 | 85.91 | 84.575 | 85.82 | 602,151 |
| 23/04/25 | 85.06 | 87.005 | 84.56 | 84.96 | 474,250 |
| 22/04/25 | 82.80 | 84.00 | 82.55 | 83.91 | 980,360 |
| 21/04/25 | 82.71 | 83.08 | 81.49 | 82.11 | 626,681 |
| 17/04/25 | 83.31 | 84.60 | 82.69 | 83.18 | 808,941 |
|
|
||||
|
|
||||
|
|